132 related articles for article (PubMed ID: 29293383)
1. Immune thrombocytopenia is associated with persistently deranged fibrosis-related seromarker profiles but low bone marrow fibrosis grades: A 2-year observational study on thrombopoietin receptor agonist treatment.
Ghanima W; Boiocchi L; Lee CS; Feng X; Geyer JT; Gudbrandsdottir S; Orazi A; Junker P; Bussel JB
Platelets; 2019; 30(2):222-228. PubMed ID: 29293383
[TBL] [Abstract][Full Text] [Related]
2. Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents.
Ghanima W; Junker P; Hasselbalch HC; Boiocchi L; Geyer JT; Feng X; Gudbrandsdottir S; Orazi A; Bussel JB
Br J Haematol; 2011 Oct; 155(2):248-55. PubMed ID: 21902682
[TBL] [Abstract][Full Text] [Related]
3. [Progression of bone marrow fibrosis with reticulin and collagen hyperplasia during treatment with the thrombopoietin receptor agonist romiplostim in a patient with immune thrombocytopenia].
Kirito K; Komatsu N
Rinsho Ketsueki; 2013 Mar; 54(3):295-9. PubMed ID: 23676646
[TBL] [Abstract][Full Text] [Related]
4. Thrombopoietin receptor agonist therapy in primary immune thrombocytopenia is associated with bone marrow hypercellularity and mild reticulin fibrosis but not other stromal abnormalities.
Boiocchi L; Orazi A; Ghanima W; Arabadjief M; Bussel JB; Geyer JT
Mod Pathol; 2012 Jan; 25(1):65-74. PubMed ID: 21841770
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow fibrosis in 66 patients with immune thrombocytopenia treated with thrombopoietin-receptor agonists: a single-center, long-term follow-up.
Ghanima W; Geyer JT; Lee CS; Boiocchi L; Imahiyerobo AA; Orazi A; Bussel JB
Haematologica; 2014 May; 99(5):937-44. PubMed ID: 24463212
[TBL] [Abstract][Full Text] [Related]
6. United Kingdom immune thrombocytopenia registry: retrospective evaluation of bone marrow fibrosis in adult patients with primary immune thrombocytopenia and correlation with clinical findings.
Rizvi H; Butler T; Calaminici M; Doobaree IU; Nandigam RC; Bennett D; Provan D; Newland AC
Br J Haematol; 2015 May; 169(4):590-4. PubMed ID: 25753327
[TBL] [Abstract][Full Text] [Related]
7. Elevated thrombopoietin levels in patients with myelofibrosis may not be due to enhanced production of thrombopoietin by bone marrow.
Wang JC; Hashmi G
Leuk Res; 2003 Jan; 27(1):13-7. PubMed ID: 12479847
[TBL] [Abstract][Full Text] [Related]
8. Cytokine changes in response to TPO receptor agonist treatment in primary immune thrombocytopenia.
Qu MM; Liu XN; Liu XG; Feng Q; Liu Y; Zhang X; Liu S; Zhang L; Li GS; Zhu YY; Lv MY; Peng J; Hou M
Cytokine; 2017 Apr; 92():110-117. PubMed ID: 28142109
[TBL] [Abstract][Full Text] [Related]
9. Increased microvesicle-associated thrombin generation in patients with immune thrombocytopenia after initiation of thrombopoietin receptor agonists.
Garabet L; Ghanima W; Hellum M; Sandset PM; Bussel JB; Tran H; Henriksson CE
Platelets; 2020; 31(3):322-328. PubMed ID: 31280643
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia.
Shehata M; Schwarzmeier JD; Hilgarth M; Hubmann R; Duechler M; Gisslinger H
J Clin Invest; 2004 Mar; 113(5):676-85. PubMed ID: 14991065
[TBL] [Abstract][Full Text] [Related]
11. Effect of thrombopoietin receptor agonists on markers of coagulation and P-selectin in patients with immune thrombocytopenia.
Garabet L; Ghanima W; Monceyron Jonassen C; Skov V; Holst R; Mowinckel MC; C Hasselbalch H; A Kruse T; Thomassen M; Liebman H; Bussel JB; Sandset PM
Platelets; 2019; 30(2):206-212. PubMed ID: 29215956
[TBL] [Abstract][Full Text] [Related]
12. Effect of thrombopoietin-receptor agonists on circulating cytokine and chemokine levels in patients with primary immune thrombocytopenia (ITP).
Gudbrandsdottir S; Ghanima W; Nielsen CH; Feng X; Hasselbalch HC; Bussel J
Platelets; 2017 Jul; 28(5):478-483. PubMed ID: 27819522
[TBL] [Abstract][Full Text] [Related]
13. Thrombopoietin concentrations in peripheral blood correlated with platelet numbers in two patients with thrombocytopenia by chronic graft-versus-host disease.
Hirayama Y; Sakamaki S; Tsuji Y; Sagawa T; Chiba H; Matsunaga T; Kuroda H; Kusakabe T; Akiyama T; Kato J; Niitsu Y
Am J Hematol; 2003 Aug; 73(4):285-9. PubMed ID: 12879435
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of bone marrow reticulin in patients with chronic immune thrombocytopenia treated with eltrombopag: Data from the EXTEND study.
Brynes RK; Orazi A; Theodore D; Burgess P; Bailey CK; Thein MM; Bakshi KK
Am J Hematol; 2015 Jul; 90(7):598-601. PubMed ID: 25801698
[TBL] [Abstract][Full Text] [Related]
15. Image analysis of platelet derived growth factor receptor-beta (PDGFRβ) expression to determine the grade and dynamics of myelofibrosis in bone marrow biopsy samples.
Bedekovics J; Szeghalmy S; Beke L; Fazekas A; Méhes G
Cytometry B Clin Cytom; 2014 Sep; 86(5):319-28. PubMed ID: 24810671
[TBL] [Abstract][Full Text] [Related]
16. X-linked thrombocytopenia with thalassemia displays bone marrow reticulin fibrosis and enhanced angiogenesis: comparisons with primary myelofibrosis.
Åström M; Hahn-Strömberg V; Zetterberg E; Vedin I; Merup M; Palmblad J
Am J Hematol; 2015 Mar; 90(3):E44-8. PubMed ID: 25421114
[TBL] [Abstract][Full Text] [Related]
17. The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study.
Mahévas M; Fain O; Ebbo M; Roudot-Thoraval F; Limal N; Khellaf M; Schleinitz N; Bierling P; Languille L; Godeau B; Michel M
Br J Haematol; 2014 Jun; 165(6):865-9. PubMed ID: 24725224
[TBL] [Abstract][Full Text] [Related]
18. Systemic transforming growth factor-beta in patients with bone marrow fibrosis--pathophysiological implications.
Rameshwar P; Chang VT; Thacker UF; Gascón P
Am J Hematol; 1998 Oct; 59(2):133-42. PubMed ID: 9766798
[TBL] [Abstract][Full Text] [Related]
19. [Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study].
Weber E; Moulis G; Mahévas M; Guy C; Lioger B; Durieu I; Hunault M; Ramanantsoa M; Royer B; Default A; Pérault-Pochat MC; Moachon L; Bernard N; Bardy G; Jonville-Bera AP; Geniaux H; Godeau B; Cathébras P
Rev Med Interne; 2017 Mar; 38(3):167-175. PubMed ID: 27793553
[TBL] [Abstract][Full Text] [Related]
20. Markers of endothelial cell activation and neutrophil extracellular traps are elevated in immune thrombocytopenia but are not enhanced by thrombopoietin receptor agonists.
Garabet L; Henriksson CE; Lozano ML; Ghanima W; Bussel J; Brodin E; Fernández-Pérez MP; Martínez C; González-Conejero R; Mowinckel MC; Sandset PM
Thromb Res; 2020 Jan; 185():119-124. PubMed ID: 31805421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
